Currently submitted to: JMIR Medical Education
Date Submitted: Jun 29, 2026
Open Peer Review Period: Jun 29, 2026 - Aug 24, 2026
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Tool or Teammate? Forming Accountable Physicians in the Age of Generative Artificial Intelligence
ABSTRACT
Since the public release of large language models, generative artificial intelligence (GenAI) has moved rapidly from novelty to daily use in clinical medicine, and medical education is now under pressure to prepare physicians for a career that will be shaped in unpredictable ways by these new technologies. In 2025, the Carl J. Shapiro Institute for Education and Research at Harvard Medical School and Beth Israel Deaconess Medical Center, in partnership with the Macy Foundation and the Association of American Medical Colleges, convened teams from eight US medical schools at Millennium Conference 2025 to develop guidance for integrating GenAI into undergraduate and graduate medical education. In this Viewpoint, the conference writing group argues that the prime question facing the field of medical education is not primarily technical but rather a deeper philosophical question about how to cultivate the core responsibilities of physicians in a world shaped by powerful “thinking” technologies. Drawing on our conference deliberations, we discuss our genuine disagreements and points of debate, especially whether GenAI is a tool or a member of the clinical team, and arrive at the concept of the “humanistic scientist,” a physician whose judgment, communication, and responsibility cannot be delegated to an algorithm. These discussions involve creating spaces to protect AI-free practice, how to assess learners who always have AI at hand, and how to prepare faculty to teach with AI. We distinguish recommendations relevant to today from commitments that will endure for the foreseeable future. Finally, we contend that accountability, not capability, should govern how AI enters medical training.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.